STRONGBRIDGE BIOPHARMA plc Operating Expenses
STRONGBRIDGE BIOPHARMA plc reported Operating Expenses of $16.93 million for the 3-month period ending 2020-12-31, per its 10-K filed 2021-03-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2021-03-03
- STRONGBRIDGE BIOPHARMA plc operating expenses for the quarter ending 2020-12-31 was $16.93M, a 15.37% decline year-over-year.
- STRONGBRIDGE BIOPHARMA plc operating expenses for the quarter ending 2020-09-30 was $15.99M, a 21.45% decline year-over-year.
- STRONGBRIDGE BIOPHARMA plc operating expenses for the quarter ending 2020-06-30 was $15.79M, a 24.53% decline year-over-year.
- STRONGBRIDGE BIOPHARMA plc operating expenses for the quarter ending 2020-03-31 was $17.95M, a 3.90% decline year-over-year.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $16.93M 10-K · filed 2021-03-03 | $32.92M derived: sum of 2 quarters · filed 2021-03-03 | $48.71M derived: sum of 3 quarters · filed 2021-03-03 | $66.66M derived: sum of 4 quarters · filed 2021-03-03 | |
| 2020-09-30 | $15.99M 10-K · filed 2021-03-03 | $31.78M derived: sum of 2 quarters · filed 2021-03-03 | $49.74M derived: sum of 3 quarters · filed 2021-03-03 | $69.74M derived: sum of 4 quarters · filed 2021-03-03 | |
| 2020-06-30 | $15.79M 10-K · filed 2021-03-03 | $33.74M derived: sum of 2 quarters · filed 2021-03-03 | $53.74M derived: sum of 3 quarters · filed 2021-03-03 | $74.10M derived: sum of 4 quarters · filed 2021-03-03 | |
| 2020-03-31 | $17.95M 10-K · filed 2021-03-03 | $37.95M derived: sum of 2 quarters · filed 2021-03-03 | $58.31M derived: sum of 3 quarters · filed 2021-03-03 | $79.23M derived: sum of 4 quarters · filed 2021-03-03 | |
| 2019-12-31 | $20.00M 10-K · filed 2021-03-03 | $40.36M derived: sum of 2 quarters · filed 2021-03-03 | $61.28M derived: sum of 3 quarters · filed 2021-03-03 | $79.96M derived: sum of 4 quarters · filed 2021-03-03 | |
| 2019-09-30 | $20.36M 10-K · filed 2021-03-03 | $41.28M derived: sum of 2 quarters · filed 2021-03-03 | $59.96M derived: sum of 3 quarters · filed 2021-03-03 | $84.07M derived: sum of 4 quarters · filed 2021-03-03 | |
| 2019-06-30 | $20.92M 10-K · filed 2021-03-03 | $39.60M derived: sum of 2 quarters · filed 2021-03-03 | $63.71M derived: sum of 3 quarters · filed 2021-03-03 | $90.47M derived: sum of 4 quarters · filed 2021-03-03 | |
| 2019-03-31 | $18.68M 10-K · filed 2021-03-03 | $42.79M derived: sum of 2 quarters · filed 2021-03-03 | $69.55M derived: sum of 3 quarters · filed 2021-03-03 | $90.22M derived: sum of 4 quarters · filed 2021-03-03 | |
| 2018-12-31 | $24.11M 10-K · filed 2020-02-28 | $25.78M 10-K · filed 2019-02-27 | $50.87M derived: sum of 2 quarters · filed 2020-02-28 | $71.53M derived: sum of 3 quarters · filed 2020-02-28 | $88.78M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-09-30 | $26.76M 10-K · filed 2020-02-28 | $28.64M 10-K · filed 2019-02-27 | $47.43M derived: sum of 2 quarters · filed 2020-02-28 | $64.67M derived: sum of 3 quarters · filed 2020-02-28 | $81.30M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $20.66M 10-K · filed 2020-02-28 | $22.54M 10-K · filed 2019-02-27 | $37.91M derived: sum of 2 quarters · filed 2020-02-28 | $54.54M derived: sum of 3 quarters · filed 2020-02-28 | $89.51M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $17.24M 10-K · filed 2020-02-28 | $19.01M 10-K · filed 2019-02-27 | $33.88M derived: sum of 2 quarters · filed 2020-02-28 | $68.84M derived: sum of 3 quarters · filed 2020-02-28 | $84.37M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $16.63M 10-K · filed 2019-02-27 | $51.60M derived: sum of 2 quarters · filed 2019-02-27 | $67.13M derived: sum of 3 quarters · filed 2019-02-27 | $79.31M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-09-30 | $34.97M 10-K · filed 2019-02-27 | $50.49M derived: sum of 2 quarters · filed 2019-02-27 | $62.67M derived: sum of 3 quarters · filed 2019-02-27 | $81.03M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-06-30 | $15.53M 10-K · filed 2019-02-27 | $27.70M derived: sum of 2 quarters · filed 2019-02-27 | $46.06M derived: sum of 3 quarters · filed 2019-02-27 | $53.69M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-03-31 | $12.18M 10-K · filed 2019-02-27 | $30.54M derived: sum of 2 quarters · filed 2019-02-27 | $38.17M derived: sum of 3 quarters · filed 2019-02-27 | $51.98M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2016-12-31 | $18.36M derived: 20-F 12 month − 6-K 9 month · filed 2017-04-04 | $25.99M derived: sum of 2 quarters · filed 2017-04-04 | $39.80M derived: sum of 3 quarters · filed 2017-04-04 | $50.73M 20-F · filed 2017-04-04 | |
| 2016-09-30 | $7.63M 6-K · filed 2016-12-30 | $21.45M derived: sum of 2 quarters · filed 2016-12-30 | $32.37M 6-K · filed 2016-12-30 | $42.74M derived: sum of 4 quarters · filed 2017-05-16 | |
| 2016-06-30 | $13.81M 6-K · filed 2016-12-30 | $24.74M 6-K · filed 2016-12-30 | $35.11M derived: sum of 3 quarters · filed 2017-05-16 | $44.75M derived: sum of 4 quarters · filed 2017-05-16 | |
| 2016-03-31 | $10.92M 6-K · filed 2017-05-16 | $21.29M derived: sum of 2 quarters · filed 2017-05-16 | $30.94M derived: sum of 3 quarters · filed 2017-05-16 | $48.17M derived: sum of 4 quarters · filed 2017-05-16 | |
| 2015-12-31 | $10.37M derived: 20-F 12 month − 6-K 9 month · filed 2017-04-04 | $20.02M derived: sum of 2 quarters · filed 2017-04-04 | $37.25M derived: sum of 3 quarters · filed 2017-04-04 | $42.85M 20-F · filed 2017-04-04 | |
| 2015-09-30 | $9.64M 6-K · filed 2016-12-30 | $26.88M derived: sum of 2 quarters · filed 2016-12-30 | $32.48M 6-K · filed 2016-12-30 | ||
| 2015-06-30 | $17.23M 6-K · filed 2016-12-30 | $22.84M 6-K · filed 2016-12-30 | |||
| 2015-03-31 | $5.61M 6-K · filed 2016-05-17 | ||||
| 2014-12-31 | $10.43M 20-F · filed 2017-04-04 | ||||
| 2013-12-31 | $5.19M 20-F · filed 2016-03-24 |